Treatment effects and comorbid diseases in 58 patients with visual snow
- PMID: 31213497
- PMCID: PMC6669936
- DOI: 10.1212/WNL.0000000000007825
Treatment effects and comorbid diseases in 58 patients with visual snow
Abstract
Objective: To evaluate pharmacologic treatment options for visual snow and to report prevalence of comorbid diseases.
Methods: Medical charts of patients with a diagnosis of visual snow at the neurology outpatient clinic were reviewed on prescribed medication, and comorbid migraine, tinnitus, and psychiatric conditions including depression and anxiety.
Results: From 2007 to 2018, 58 patients were diagnosed with visual snow. Comorbid migraine was present in 51.7% of patients, lifetime depression in 41.4%, and lifetime anxiety in 44.8%. Lamotrigine was prescribed most frequently (26/58) and resulted in partial remission of symptoms in 5/26 (19.2%). No patients reported complete remission. Adverse events occurred in 13/26 (50.0%) patients. None of the other prescribed drugs (valproate [n = 7], topiramate [n = 4], acetazolamide [n = 2], flunarizine [n = 1]) led to improvement except for topiramate in one patient, who discontinued, however, because of adverse events.
Conclusions: Of medication prescribed (lamotrigine, valproate, acetazolamide, flunarizine), only lamotrigine afforded some improvement in a small minority of patients. Migraine, depression, anxiety, and tinnitus were common comorbid diseases.
Classification of evidence: This study provides Class IV evidence that for some patients with visual snow, lamotrigine resulted in partial remission of symptoms.
Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
Figures
Comment in
-
Comment: Time for neurologists to see visual snow.Neurology. 2019 Jul 23;93(4):153. doi: 10.1212/WNL.0000000000007824. Epub 2019 Jun 18. Neurology. 2019. PMID: 31213496 No abstract available.
References
-
- Schankin CJ, Maniyar FH, Digre KB, et al. . “Visual snow”: a disorder distinct from persistent migraine aura. Brain 2014;137:1419–1428. - PubMed
-
- Puledda F, Schankin C, Digre K, Goadsby PJ. Visual snow syndrome: what we know so far. Curr Opin Neurol 2018;31:52–58. - PubMed
-
- Lauschke JL, Plant GT, Fraser CL. Visual snow: a thalamocortical dysrhythmia of the visual pathway? J Clin Neurosci 2016;28:123–127. - PubMed
-
- Unal-Cevik I, Yildiz FG. Visual snow in migraine with aura: further characterization by brain imaging, electrophysiology, and treatment: case report. Headache 2015;55:1436–1441. - PubMed
-
- Wang YF, Fuh JL, Chen WT, Wang SJ. The visual aura rating scale as an outcome predictor for persistent visual aura without infarction. Cephalalgia 2008;28:1298–1304. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials